Table of Contents
Overview
New York, NY – May 21, 2025 – Global Digital Mammography Market size is expected to be worth around US$ 6.8 billion by 2033 from US$ 2.5 billion in 2023, growing at a CAGR of 10.5% during the forecast period 2024 to 2033.
The global digital mammography market is witnessing substantial growth, driven by increasing awareness of early breast cancer detection, advancements in imaging technologies, and expanding government initiatives for women’s health screening programs. Digital mammography, which uses low-dose X-rays to capture high-resolution images of the breast, has become a widely adopted diagnostic tool due to its improved accuracy, faster image acquisition, and efficient storage capabilities compared to conventional film-based methods.
The adoption of full-field digital mammography (FFDM) systems has surged globally, especially in developed regions such as North America and Europe, due to favorable reimbursement policies and the presence of well-established healthcare infrastructure. In addition, emerging economies in Asia-Pacific and Latin America are increasingly investing in digital imaging solutions, supported by growing healthcare expenditure and awareness campaigns by public health authorities.
Hospitals, diagnostic centers, and mobile screening units are key end users of digital mammography systems. The integration of artificial intelligence (AI) in image analysis is further enhancing diagnostic precision and workflow efficiency, reducing radiologist workload, and supporting early intervention.
With the global burden of breast cancer rising steadily, the digital mammography market is expected to maintain upward momentum. The market outlook remains optimistic as healthcare providers increasingly prioritize preventive diagnostics and adopt advanced imaging modalities to improve patient outcomes.
Key Takeaways
- In 2023, the market for Digital Mammography generated a revenue of US$ 2.5 billion, with a CAGR of 10.5%, and is expected to reach US$ 6.8 billion by the year 2033.
- The product type segment is divided into 2D full field digital mammography, 3D full field digital mammography, and contrast enhanced digital mammography, with 2D full field digital mammography taking the lead in 2023 with a market share of 55.2%.
- Considering end-use, the market is divided into hospitals, diagnostic centers, and others. Among these, hospitals held a significant share of 63.8%.
- North America led the market by securing a market share of 40.3% in 2023.
Segmentation Analysis
- Product Type Analysis: In 2023, 2D full-field digital mammography held a dominant 55.2% market share due to its established role in breast cancer screening and cost-effectiveness compared to 3D systems. Its widespread adoption is supported by high image quality, affordability, and technological improvements that reduce radiation exposure. As global healthcare systems emphasize preventive care and early detection—especially in cost-sensitive regions—2D systems are expected to maintain strong demand for routine breast screening procedures.
- End-Use Analysis: Hospitals accounted for 63.8% of the digital mammography market in 2023, driven by increasing investments in advanced diagnostic equipment and rising breast cancer awareness. These facilities are expanding breast care units and adopting digital systems to improve diagnostic accuracy and patient throughput. Enhanced image resolution and faster processing support timely treatment decisions. Growth in healthcare infrastructure, particularly in emerging markets, is anticipated to further increase hospital-based adoption of digital mammography technologies.
Market Segments
By Product Type
- 2D Full Field Digital Mammography
- 3D Full Field Digital Mammography
- Contrast Enhanced Digital Mammography
By End-use
- Hospitals
- Diagnostic Centers
- Others
Regional Analysis
North America Dominates the Digital Mammography Market
In 2023, North America led the global digital mammography market, accounting for 40.3% of the total revenue. This dominance is attributed to heightened awareness of breast cancer and the increasing emphasis on early detection. Technological advancements have significantly improved image resolution and diagnostic speed, supporting widespread adoption across hospitals and clinics. Favorable healthcare policies and organized screening programs have further accelerated the use of digital mammography systems in the region.
The growing number of women undergoing routine breast cancer screening and continuous investment in healthcare innovation have reinforced market growth. Additionally, ongoing research aimed at enhancing the performance and cost-efficiency of digital mammography systems is making the technology more accessible. North America’s robust healthcare infrastructure and focus on preventive diagnostics position it as a key contributor to the market’s expansion.
Asia Pacific Expected to Register the Fastest CAGR
The Asia Pacific region is projected to experience the highest compound annual growth rate (CAGR) in the digital mammography market during the forecast period. Rising breast cancer awareness, driven by public health campaigns such as Greater Chennai Corporation’s screenings—which reached approximately 117,000 women in 2020–2021—is fostering increased adoption of screening technologies.
Government-led initiatives and partnerships, such as the PINK Project launched in Punjab with Roche Pharma India and Niramai Health, are improving access to early detection tools. Additionally, expanding healthcare infrastructure and rising healthcare investments in countries like India and China are expected to support market growth. As disposable income rises and healthcare systems modernize, demand for accurate and efficient diagnostic solutions like digital mammography is anticipated to grow substantially across the region.
Emerging Trends
- The adoption of digital breast tomosynthesis (DBT) is increasing, as it allows layer-by-layer imaging that improves the detection of invasive cancers and reduces recall rates compared with standard full-field digital mammography.
- Artificial intelligence (AI) driven computer-aided detection is being integrated into screening workflows, with over 20 FDA-approved AI applications available for breast imaging, although uptake remains variable across facilities.
- Mobile mammography programs are expanding to reach underserved populations, offering low-cost or free screenings in community settings; however, adherence to annual guidelines in mobile settings ranged from 12% to 34%, and to biennial guidelines from 40% to 48% among participants.
Use Cases
- Population-based screening: Digital mammography is used in routine screening programs. In 2022, 59.1% of U.S. women aged 40–49 and 76.5% of those aged 50–74 reported having had a mammogram within the past two years.
- Clinical decision support: Mammography exams were ordered or provided during 27.3 million physician office visits in 2019, supporting diagnostic evaluations and follow-up care.
- Quality assurance and notification: Following the 2023 MQSA Final Rule (effective September 10, 2024), facilities have been required to notify patients of breast tissue density, prompting supplemental ultrasound or MRI in dense-breast cases.
Conclusion
The global digital mammography market is poised for sustained growth, driven by rising breast cancer awareness, technological advancements, and expanding access to screening services. With 2D full-field systems maintaining dominance and AI integration enhancing diagnostic accuracy, hospitals remain the primary end-users.
North America leads in adoption, while Asia-Pacific is expected to witness the fastest growth due to public health initiatives and increasing healthcare investments. Emerging trends such as tomosynthesis and mobile screening units further support early detection efforts. As preventive diagnostics gain prominence, digital mammography continues to play a critical role in improving breast cancer outcomes globally.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
